Diabetes, high blood pressure, obesity and smoking causes the blood arteries to marrow and limit the blood supply to
the heart. It is estimated that 382 billion people throughout the world have diabetes. Environmental factors such as
foods, viruses, toxins and unbalanced work life play a role in development of diabetes. Growing number of patients
with these vascular diseases are expected to proliferate the demand for atherectomy devices. Adopting advanced
technology by using laser, ultraviolet radiation and recombinant issue technology and 3D image generation provides
a better scope for the Atherectomy devices market. Added benefits such as minimal incisions, higher surgical
restoration rate, low postoperative complications increase more patients opting for atherectomy devices.
New technological advancements and the recent FDA approval of Two drug coated balloons are increasing
atherectomy procedural volume and driving growth in the demand for atherectomy devices Recalls of medical devices
has beena major issue in pharmaceutical industry. Every device should maintain the standard quality and safety
measures set by the Food and Drug Administration (FDA). All the manufacturing firms should ensure that the products
are safe and do not endanger the end consumer. Athrectomy devices face a tough competition from Catheter (Tornus)
which has been developed for chronic total occlusion recanalization. However, Catheter has a lower success rate of
only 77% as compared to the traditional atherectomy devices with 95%. Tornus catheter is also associated with longer
procedural duration time with 144 minutes versus the atherectomy devices 115 minutes.
Get a Sample Copy of This Report @
https://www.millioninsights.com/industry-reports/atherectomy-devices-market/request-sample
Lack of product differentiation forms a major challenge in the atherectomy Devices market. Most companies trying to
enter the market find it hard to overcome the product differentiation because they require high investment and lack
resources to create products that can compete with the existing ones. High cost and limited awareness in certain
regions of the world act as a restraint for the market growth. Atherectomy technique is a popular substitute for stents
and angioplasty treatments. In stents and angioplasty, the deposited plaque is pushed inside the blood vessel, however
in atherectomy the plaque is removed by using surgical methods. The technique has advantages over the other
methods by providing increased wound healing rate The Atherectomy Devices Market has been classified on the basis
of its device functions such as rotational, orbital, excimer laser, excisional, directional and Jetstream atherectomy. The
largest share of the market is occupied by orbital and directional atherectomy due to minimal invasive treatment,
blood flow restoration, reduction in procedure time and application in more complex cases. Market players are coming
with better techniques and products to meet the requirement of the consumers.
The Atherectomy Devices Market is segmented on the basis of geography such as North America, Europe, Asia pacific.
North America is the leading player in the market followed by Europe. Peripheral artery disease affects nearly 10
million people and around 720,000 die every year due to heart attack in US making it the potential market for the
devices. Higher number of surgeries are being performed in US and Europe due to better awareness among people
and also availability of resources making them the leading regions in the market. Asia pacific can be a potential market
for atherectomy devices since countries such as India and china possess the largest number of cardiac patients with
an annual incidence of 7 million strokes. Tobacco consumption is rapidly increasing in south Asian countries in
conjunction with economic expansion increasing their risk of artery diseases.